Episode 8: Medicare and Biosimilars
This week on the podcast, we’re pleased to welcome our guest, Leigh Purvis, MPA. Purvis is the director of health services research at AARP’s public policy institute. Her work focuses on a variety of prescription drug and mental health-related issue, with an emphasis on prescription drug pricing, biologic drugs, and prescription drug coverage under Medicare. Purvis joined us by phone to talk a...
8m May 06, 2018
8m
Episode 7: Oncology Biosimilars
This week, we're delving into the world of supportive care and anticancer biosimilars with an oncology expert, Robert M. Rifkin, MD, FACP.
6m Apr 22, 2018
6m
Episode 6: The Nebraska Rheumatology Society
Today, we're talking about state-level legislation concerning the substitution of interchangeable biosimilars, and how 1 specific piece of biosimilars-focused legislation led to the formation of the Nebraska Rheumatology Society. Our guest this week is Marcus Snow, MD, a rheumatologist at the University of Nebraska Medical Center, and assistant professor of rheumatology at the University of Neb...
11m Apr 05, 2018
11m
Episode 5: Policy and Biosimilars
Episode 5: Policy and Biosimilars by The Center for Biosimilars
13m Mar 20, 2018
13m
Episode 4: Creating a Vibrant Biosimilars Market
Episode 4: Creating a Vibrant Biosimilars Market by The Center for Biosimilars
14m Mar 16, 2018
14m
Episode 3: Pricing
Episode 3: Pricing by The Center for Biosimilars
18m Mar 02, 2018
18m
Episode 2: Nonmedical Switching
Episode 2: Nonmedical Switching by The Center for Biosimilars
11m Feb 14, 2018
11m
Episode 1: Interchangeability
Episode 1: Interchangeability by The Center for Biosimilars
15m Feb 02, 2018
15m